Dr. George Romar is a highly accomplished dermatologist specializing in complex medical dermatology, contact dermatitis, alopecia, and medical innovation. Dr. Romar graduated magna cum laude from Harvard Medical School, where he was honored for his outstanding academic achievements and contributions to dermatological research. He has a particular focus on drug hypersensitivity reactions, graft-versus-host disease (GVHD), and cutaneous T-cell responses. He completed his dermatology residency at Albert Einstein College of Medicine-Montefiore, where he was recognized for his clinical excellence and leadership skills.

Professional Associations Dr. Romar is an active member of several professional associations, including:

• American Academy of Dermatology (AAD)
• Society for Investigative Dermatology (SID)
• American Society for Dermatologic Surgery (ASDS)

Innovation & Research Dr. Romar has unique expertise in research and innovation, significantly contributing to the fields of dermatology and dermatologic surgery. His work on drug hypersensitivity reactions, graft-versus-host disease, and cutaneous T-cell responses has been published in esteemed journals. He has presented his findings at numerous national and international conferences, reflecting his commitment to advancing dermatological care and knowledge. Dr. Romar's research continues to influence clinical practices and improve patient outcomes.

Selected Publications Peer-Reviewed Journal Publications

• *Romar GA, *Li DJ, *Velasquez GA, Schunkert EM, Foreman RK, Divito SJ. “Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.” JAMA Dermatol. 2023 Aug 1;159(8):830-836.
• *Romar GA, *Li DJ, Hsieh PC, Wells M, Foreman RK, Lian CG, Divito SJ. “Histologic features of GVHD-associated angiomatosis: Insights into pathophysiology and treatment.” J Am Acad Dermatol. 2020 Sep;83(3):914-917.
• Romar GA, Kupper TS, Divito SJ. “Research Techniques Made Simple: Techniques to Assess Cell Proliferation.” J Invest Dermatol. 2016 Jan; 136(1):e1-7.
• Romar G, and Matthews KRW. “Considerations on U.S. Government Involvement in STEM Education and Early Childhood Interventions.” J Sci Pol and Gov (2013) Jun; 3(1):1-7. Abstracts - International
• Romar GA, Hsieh PC, Compton LA, Chiluiza D, and Divito SJ. “Skin resident memory T cells survive chemotherapy and mediate drug hypersensitivity reactions in the setting of profound lymphopenia.” 2018 International Investigative Dermatology, Orlando, FL. (2018)
• Hsieh PC, Romar GA, Wells M, Foreman R, Lian CG, and Divito SJ. “Insights into GVHD-associated Angiomatosis.” 2018 International Investigative Dermatology, Orlando, FL. (2018)
• Romar GA, and Divito SJ. “Retrospective Analysis Of SJS/TEN Cases Reveals Need For Diagnostic Test To Determine Culprit Drug.” EAACI 8th Drug Hypersensitivity Meeting, Amsterdam, The Netherlands. (2018)
• Romar GA, Hsieh P, Compton LA, Divito SJ. “Skin resident memory T cells survive chemotherapy and Immediate drug hypersensitivity reactions in the setting of profound lymphopenia.” International Investigative Dermatology, Orlando, FL. (2018) Abstracts - National
• Divito SJ, Elco CP, Romar GA, Cutler C, Kupper, TS. “Host skin T cells survive chemotherapy and transplant conditioning regiments and are present during acute GVHD.” J Invest Dermatol (2016) 136(5), S40.
• Romar GA, Compton LA, Kupper TS, Divito SJ. “Development of neutrophilic dermatoses in profoundly neutropenic patients.” J Invest Dermatol (2016) 136(5), S31.
• Divito SJ, Romar GA, Compton LA, and Kupper TS. “Neutrophil and lymphocyte-mediated skin disease despite profound leukopenia.” J Invest Dermatol (2015) 135, S28–S48.